Our Vision

Galvani is developing therapies to treat disease through implant-based direct modulation of specific neural signals to organs central in chronic disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimise the therapy.

Background

Galvani Bioelectronics is a pioneering medical research company dedicated to the development of bioelectronic medicines to treat chronic diseases. Formed through a partnership between two global healthcare companies, GlaxoSmithKline (GSK) and Verily Life Sciences (formerly Google Life Sciences), a subsidiary of Alphabet Inc., Galvani Bioelectronics combines GSK’s life science knowledge with Verily’s expertise in software and electronics for clinical applications.

THERAPEUTIC FOCUS AREAS

Immunomodulatory Non-immunomodulatory
Rheumatoid Arthritis* Bladder Dysfunction
Post-surgical complications* Chronic Obstructive Pulmonary Disease (COPD)
Multiple Sclerosis Hypertension
Systemic Lupus Erythematosus (SLE) Sleep Apnea
Psoriatic Arthritis Type II Diabetes
Ankylosing Spondylitis
Crohn's Disease
Ulcerative Colitis
Type 1 Diabetes
*Currently in Clinical Development

LOCATIONS

GALVANI BIOELECTRONICS Ltd

Gunnels Wood Road
Stevenage
Hertfordshire
SG1 2NY
United Kingdom
Find on Maps

+44 (0)800 3688514

GALVANI BIOELECTRONICS Inc.

269 E Grand Ave
South San Francisco
CA 94080
USA
Find on Maps

 

1250 South Collegeville Rd.
Upper Providence
PA 19426
USA
Find on Maps

5 Moore Drive
Research Triangle Park
NC 27709
USA
Find on Maps